Novel HIV-1 Knockdown Targets Identified by an Enriched Kinases/Phosphatases shRNA Library Using a Long-Term Iterative Screen in Jurkat T-Cells

HIV-1 is a complex retrovirus that uses host machinery to promote its replication. Understanding cellular proteins involved in the multistep process of HIV-1 infection may result in the discovery of more adapted and effective therapeutic targets. Kinases and phosphatases are a druggable class of proteins critically involved in regulation of signal pathways of eukaryotic cells. Here, we focused on the discovery of kinases and phosphatases that are essential for HIV-1 replication but dispensable for cell viability. We performed an iterative screen in Jurkat T-cells with a short-hairpin-RNA (shRNA) library highly enriched for human kinases and phosphatases. We identified 14 new proteins essential for HIV-1 replication that do not affect cell viability. These proteins are described to be involved in MAPK, JNK and ERK pathways, vesicular traffic and DNA repair. Moreover, we show that the proteins under study are important in an early step of HIV-1 infection before viral integration, whereas some of them affect viral transcription/translation. This study brings new insights for the complex interplay of HIV-1/host cell and opens new possibilities for antiviral strategies.

[1]  M. Giacca,et al.  Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. , 1999, AIDS.

[2]  Narasimhan J. Venkatachari,et al.  Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR). , 2006, Antiviral research.

[3]  M. Malim,et al.  Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding , 2000, Journal of Virology.

[4]  Pauline E. Chugh,et al.  Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy , 2008, Retrovirology.

[5]  P. Pitha,et al.  Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. , 2000, Virology.

[6]  L. Selig,et al.  HEED, the Product of the Human Homolog of the Murineeed Gene, Binds to the Matrix Protein of HIV-1* , 1999, The Journal of Biological Chemistry.

[7]  L. Mullenders,et al.  Nucleotide excision repair and its interplay with transcription. , 2003, Toxicology.

[8]  B. Hemmings,et al.  NDR family of AGC kinases – essential regulators of the cell cycle and morphogenesis , 2003, FEBS letters.

[9]  Donna R. Maglott,et al.  Human immunodeficiency virus type 1, human protein interaction database at NCBI , 2008, Nucleic Acids Res..

[10]  F. Hanaoka,et al.  Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair , 1997, Journal of virology.

[11]  G. Chrousos,et al.  HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. , 1998, Virology.

[12]  D. Margolis,et al.  Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells. , 2008, The Journal of infectious diseases.

[13]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[14]  A. Dayton,et al.  Hitting HIV where it hides , 2008, Retrovirology.

[15]  S. Lampel,et al.  The druggable genome: an update. , 2005, Drug discovery today.

[16]  Charles Flexner,et al.  HIV drug development: the next 25 years , 2007, Nature Reviews Drug Discovery.

[17]  W. Greene,et al.  Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy , 2002, Nature Medicine.

[18]  S. Goff,et al.  Host factors exploited by retroviruses , 2007, Nature Reviews Microbiology.

[19]  J. Loffing,et al.  Sgk kinases and their role in epithelial transport. , 2006, Annual review of physiology.

[20]  A. Greenway,et al.  HIV-1 Nef control of cell signalling molecules: Multiple strategies to promote virus replication , 2003, Journal of Biosciences.

[21]  M. Ott,et al.  HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. , 2004, Molecular cell.

[22]  V. Trouplin,et al.  Retracing the Evolutionary Pathways of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors: Virus Fitness in the Absence and in the Presence of Drug , 2000, Journal of Virology.

[23]  Amy S. Espeseth,et al.  Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies , 2009, PLoS pathogens.

[24]  H. Enslen,et al.  Modulation of HIV‐1 infectivity by MAPK, a virion–associated kinase , 1998, The EMBO journal.

[25]  D. Weiner,et al.  Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism , 2005, Cell Death and Differentiation.

[26]  R. König,et al.  Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication , 2008, Cell.

[27]  D. Gabuzda,et al.  ERK MAP Kinase Links Cytokine Signals to Activation of Latent HIV-1 Infection by Stimulating a Cooperative Interaction of AP-1 and NF-κB* , 1999, The Journal of Biological Chemistry.

[28]  Pamela A Silver,et al.  HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases. , 2005, Virology.

[29]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[30]  R. Kole,et al.  HIV-1 preferentially binds receptors copatched with cell-surface elastase. , 2003, Blood.

[31]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[32]  M. Geng,et al.  Sulfated polymannuroguluronate, a novel anti‐acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein , 2006, Journal of neurochemistry.

[33]  K. Kok,et al.  siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication , 2009, Retrovirology.

[34]  T. Hunter,et al.  Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.

[35]  M. Stevenson.  Can HIV be cured? , 2008, Scientific American.

[36]  P. André,et al.  Human Polycomb group EED protein negatively affects HIV-1 assembly and release , 2007, Retrovirology.

[37]  Ashok Kumar,et al.  Activation of JNK-dependent pathway is required for HIV viral protein R-induced apoptosis in human monocytic cells. INVOLVEMENT OF ANTIAPOPTOTIC BCL2 AND c-IAP1 GENES. , 2012, The Journal of Biological Chemistry.

[38]  S. Nekhai,et al.  REGULATION OF HIV‐1 TRANSCRIPTION BY PROTEIN PHOSPHATASE 1 , 2006, Current HIV research.

[39]  J. Sodroski,et al.  CD4-Induced Conformational Changes in the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for Virus Entry and Neutralization , 1998, Journal of Virology.

[40]  L. Naldini,et al.  Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters , 2005, Nature Biotechnology.

[41]  Amy S. Espeseth,et al.  Genome-scale RNAi screen for host factors required for HIV replication. , 2008, Cell host & microbe.

[42]  Philip Cohen.  25 years with HIV , 2006 .

[43]  Kuan-Teh Jeang,et al.  A Genome-wide Short Hairpin RNA Screening of Jurkat T-cells for Human Proteins Contributing to Productive HIV-1 Replication* , 2009, The Journal of Biological Chemistry.

[44]  J. Chai,et al.  Structural basis of EZH2 recognition by EED. , 2007, Structure.

[45]  J. Mouscadet,et al.  The Human Polycomb Group EED Protein Interacts with the Integrase of Human Immunodeficiency Virus Type 1 , 2003, Journal of Virology.

[46]  S. Goff,et al.  Knockdown Screens to Knockout HIV-1 , 2008, Cell.